The Global Health Body Sounds Concern Over Acute Lack of Weight-Loss Medications
Under one in 10 individuals that would benefit from weight-loss injections including Wegovy have access to them, warns the World Health Organization as it publishes its inaugural guidance on the medications.
Given in excess of 1,000,000,000 people worldwide now obese, it is advocating for increased and just availability to these injectable treatments.
Based on forecasts, in excess of 2,000,000,000 will be living with obesity by 2030 without intervention.
"The new guidelines affirms that excess weight is a lifelong illness that can be managed with comprehensive and lifelong support," said its chief Tedros Adhanom Ghebreyesus.
Substantial prices, constrained manufacturing, and distribution challenges are major hurdles to universal access to the treatments that can aid individuals in losing significant body mass, notes the body.
Weight-Loss Drug Scarcity
Even under the present most favorable case, the supply of these medications could only cover around 100 million people – fewer than 10% of those who need them, according to the WHO.
The guideline encourages countries and companies to expand availability, through measures such as patent sharing.
The intellectual property rights on a key compound – the core component of the drug Wegovy – is scheduled to end in several countries in 2026.
How Obesity Jabs Operate
These medications replicate a body's own hormone to slow digestion, curb appetite and boost satiety so individuals consume fewer calories.
People typically see weight reduction within a few weeks of commencing the regular doses.
Studies suggests patients may put most of the weight back on within a year of discontinuing the treatment, as their normal food cravings come back.
Being overweight or obese increases your likelihood for experiencing health problems, such as type 2 diabetes, cardiovascular issues, brain attack, and certain malignancies.
Obesity impacts individuals in countries worldwide and was linked to 3.7 million deaths worldwide in 2024, as per the WHO.